Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/123840
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers |
Autor: | Sánchez-Aragó, María CSIC; Formentini, Laura CSIC ORCID; Martínez-Reyes, Inmaculada CSIC ORCID; García-Bermúdez, Javier CSIC ORCID; Santacatterina, Fulvio CSIC ORCID; Sánchez-Cenizo, Laura CSIC; Willers, Imke M. CSIC; Cuezva, José M. CSIC ORCID | Fecha de publicación: | 22-abr-2013 | Editor: | Macmillan Publishers | Citación: | Oncogenesis 2e46: 1-11 (2013) | Resumen: | Recent findings in colon cancer cells indicate that inhibition of the mitochondrial Hþ-adenosine triphosphate (ATP) synthase by the ATPase inhibitory factor 1 (IF1) promotes aerobic glycolysis and a reactive oxygen species (ROS)-mediated signal that enhances proliferation and cell survival. Herein, we have studied the expression, biological relevance, mechanism of regulation and potential clinical impact of IF1 in some prevalent human carcinomas. We show that IF1 is highly overexpressed in most (490%) of the colon (n¼64), lung (n¼30), breast (n¼129) and ovarian (n¼10) carcinomas studied as assessed by different approaches in independent cohorts of cancer patients. The expression of IF1 in the corresponding normal tissues is negligible. By contrast, the endometrium, stomach and kidney show high expression of IF1 in the normal tissue revealing subtle differences by carcinogenesis. The overexpression of IF1 also promotes the activation of aerobic glycolysis and a concurrent ROS signal in mitochondria of the lung, breast and ovarian cancer cells mimicking the activity of oligomycin. IF1-mediated ROS signaling activates cell-type specific adaptive responses aimed at preventing death in these cell lines. Remarkably, regulation of IF1 expression in the colon, lung, breast and ovarian carcinomas is exerted at post-transcriptional levels. We demonstrate that IF1 is a short-lived protein (t1/2B100 min) strongly implicating translation and/or protein stabilization as main drivers of metabolic reprogramming and cell survival in these human cancers. Analysis of tumor expression of IF1 in cohorts of breast and colon cancer patients revealed its relevance as a predictive marker for clinical outcome, emphasizing the high potential of IF1 as therapeutic target. | URI: | http://hdl.handle.net/10261/123840 | DOI: | 10.1038/oncsis.2013.9 | Identificadores: | doi: 10.1038/oncsis.2013.9 issn: 2157-9024 |
Aparece en las colecciones: | (CBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
JM_Cuezva_Expression_Regulation_.pdf | 3,07 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
41
checked on 11-abr-2024
SCOPUSTM
Citations
74
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
64
checked on 23-feb-2024
Page view(s)
368
checked on 21-abr-2024
Download(s)
291
checked on 21-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.